These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23124150)

  • 1. Bronchial asthma developing after 15 years of immunosuppressive treatment following renal transplantation.
    Watanabe H; Uruma T; Tsunoda T; Ishii H; Tazaki G; Kondo T
    Intern Med; 2012; 51(21):3057-60. PubMed ID: 23124150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the new immunosuppressive agents on the occurrence of malignancies after renal transplantation.
    Marcén R; Galeano C; Fernández-Rodriguez A; Jiménez-Alvaro S; Teruel JL; Rivera M; Burgos FJ; Quereda C
    Transplant Proc; 2010 Oct; 42(8):3055-7. PubMed ID: 20970609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are renal transplant recipients on CsA-based immunosuppressive regimens more likely to develop skin cancer than those on azathioprine and prednisolone?
    Jensen P; Hansen S; Møller B; Leivestad T; Pfeffer P; Fauchald P
    Transplant Proc; 1999; 31(1-2):1120. PubMed ID: 10083500
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoimmune haemolytic anaemia after ABO-match, ABDR full match kidney transplantation.
    Rougier JP; Viron B; Ronco P; Khayat R; Michel C; Mignon F
    Nephrol Dial Transplant; 1994; 9(6):693-7. PubMed ID: 7970098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of recurrent IgA nephropathy following renal transplantation under tacrolimus (FK506)].
    Takao T; Hatori M; Ichimaru N; Honda M; Nonomura N; Matsumiya K; Kokado Y; Takahara S; Okuyama A; Miyamoto M; Yokoyama K; Imai E; Kyo M
    Hinyokika Kiyo; 1997 Sep; 43(9):661-4. PubMed ID: 9365847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.
    Thierry A; Le Meur Y; Ecotière L; Abou-Ayache R; Etienne I; Laurent C; Vuiblet V; Colosio C; Bouvier N; Aldigier JC; Rerolle JP; Javaugue V; Gand E; Bridoux F; Essig M; Hurault de Ligny B; Touchard G
    Transpl Int; 2016 Jan; 29(1):23-33. PubMed ID: 26729582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary mutagenic activity after different immunosuppressive protocols in renal transplant patients.
    Fracasso ME; Barba A; Tessari G; Gasperini S; Brunello F
    Mutat Res; 1993 Dec; 319(4):279-83. PubMed ID: 7504201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prednisolone and azathioprine in IgA nephropathy - a ten-year follow-up study.
    Goumenos DS; Davlouros P; El Nahas AM; Ahuja M; Shortland JR; Vlachojannis JG; Brown CB
    Nephron Clin Pract; 2003; 93(2):C58-68. PubMed ID: 12616032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifying cyclosporine associated renal allograft dysfunction.
    Mohapatra N; Vanikar AV; Patel RD; Trivedi HL
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):770-4. PubMed ID: 19736471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gingival overgrowth in dogs associated with clinically relevant cyclosporine blood levels: observations in a canine renal transplantation model.
    Nam HS; McAnulty JF; Kwak HH; Yoon BI; Hyun C; Kim WH; Woo HM
    Vet Surg; 2008 Apr; 37(3):247-53. PubMed ID: 18394071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of disseminated superficial actinic porokeratosis subsequent to renal transplantation.
    Matsushita S; Kanekura T; Kanzaki T
    J Dermatol; 1997 Feb; 24(2):110-2. PubMed ID: 9065706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term bone loss after renal transplantation: comparison of immunosuppressive regimens.
    McIntyre HD; Menzies B; Rigby R; Perry-Keene DA; Hawley CM; Hardie IR
    Clin Transplant; 1995 Feb; 9(1):20-4. PubMed ID: 7742578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can immunosuppressive drugs slow the progression of IgA nephropathy?
    Goumenos D; Ahuja M; Shortland JR; Brown CB
    Nephrol Dial Transplant; 1995; 10(7):1173-81. PubMed ID: 7478120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of subclinical IgA nephropathy and cyclosporin associated arteriolopathy diagnosed by non-episode biopsy of graft kidney after renal transplantation].
    Namba Y; Kyakuno M; Nakamura T; Yamashiro H; Okada M; Toki K; Ichimaru N; Kokado Y; Takahara S; Okuyama A; Oka K; Imai E; Kyo M
    Hinyokika Kiyo; 1999 May; 45(5):349-53. PubMed ID: 10410319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lip carcinoma in renal allograft recipient with long-term immunosuppressive therapy.
    Regev E; Zeltser R; Lustmann J
    Oral Surg Oral Med Oral Pathol; 1992 Apr; 73(4):412-4. PubMed ID: 1574300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does mycophenolate mofetil increase the incidence of infections in renal transplant recipients?
    Prokopenko E; Scherbakova E; Vatazin A; Pasov S; Budnikova N; Agafonova S
    Drugs Exp Clin Res; 2005; 31(5-6):199-205. PubMed ID: 16425976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of immunosuppression on the incidence of early subclinical renal allograft rejection: implications for protocol biopsy policy.
    Roberts IS; Stratopoulos C; Zilvetti M; Reddy S; Friend PJ
    Transpl Int; 2009 Aug; 22(8):831-6. PubMed ID: 19386079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of Chronic Myelogenic Leukemia (CML) with imatinib after renal transplantation.
    Eishei Oskuei A; Makhdoomi K; Abkhiz S; Vossoghian S; Farrokhpour M
    Arch Iran Med; 2014 May; 17(5):388-90. PubMed ID: 24784871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.